La Jolla, California
United States
31
2026-02-05
22
2025-05-06
These are the the leading inventors for applications assigned to EpicentRx, Inc.:
EpicentRx, Inc. based in La Jolla, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
CO-CRYSTALS OF 2-BROMO-1-(3,3-DINITROAZETIDIN-1-YL)ETHANONE AND METHODS
#2 | 2025-12-25TUMOR SELECTIVE TATA-BOX AND CAAT-BOX MUTANTS
#3 | 2025-09-18SYSTEMS AND METHODS TO IMPROVE EXERCISE TOLERANCE
#4 | 2025-05-22MEDICATION INFUSION DEVICES, SYSTEMS, AND METHODS
#5 | 2025-05-01COMPOSITIONS AND METHODS FOR TREATMENT OF NAFLD AND NASH AND RELATED DYSLIPIDEMIAS
#6 | 2025-03-27MEDICATION INFUSION DEVICES, SYSTEMS, AND METHODS
#7 | 2025-03-06IMMUNOMODULATORY FUSION PROTEINS
#8 | 2024-11-14METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS
#9 | 2024-09-05 ✅ Patent 12,291,726 granted on 2025-05-06A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoter
#10 | 2024-05-09 ✅ Patent 12,357,608 granted on 2025-07-15METHODS AND COMPOSITIONS UTILIZING RRx-001 COMBINATION THERAPY FOR RADIOPROTECTION
#11 | 2023-07-27MONO- AND MULTI-VALENT SARS-COV- 2 ADENOVIRAL VECTOR VACCINES AND SARS-COV-2 IMMUNE GLOBULIN AND METHODS OF USE
#12 | 2023-07-27 ✅ Patent 12,357,607 granted on 2025-07-15COMPOSITIONS AND METHODS FOR INTRAVENOUS ADMINISTRATION OF 2-BROMO-1-(3,3-DINITROAZETIDIN-1-YL)ETHANONE
#13 | 2022-04-28 ✅ Patent 12,280,123 granted on 2025-04-22Recombinant adenoviruses carrying transgenes
#14 | 2022-02-24 ✅ Patent 11,701,351 granted on 2023-07-18Treatment of gliomas using organonitro compound combination therapy
#15 | 2021-11-02 ✅ Patent 11,160,784 granted on 2021-11-02Treatment of brain metastases using organonitro compound combination therapy
#16 | 2021-08-12 ✅ Patent 12,048,793 granted on 2024-07-30Medication infusion devices, systems, and methods
#17 | 2021-06-17 ✅ Patent 12,109,348 granted on 2024-10-08Medication infusion devices, systems, and methods
#18 | 2021-05-13 ✅ Patent 12,054,530 granted on 2024-08-06Immunomodulatory fusion proteins
#19 | 2021-01-21 ✅ Patent 12,295,976 granted on 2025-05-13Personalized cancer vaccines
#20 | 2020-11-05 ✅ Patent 11,510,901 granted on 2022-11-29Methods and compositions utilizing RRx-001 combination therapy for radioprotection
#21 | 2020-08-13 ✅ Patent 11,744,859 granted on 2023-09-05Compositions and methods for parenteral administration of therapeutic agents
#22 | 2020-07-16 ✅ Patent 11,834,492 granted on 2023-12-05Human IL-10 receptor alpha fusion proteins
#23 | 2020-05-21 ✅ Patent 11,008,287 granted on 2021-05-18Sulfoxyalkyl organonitro and related compounds and pharmaceutical compounds for use in medicine
#24 | 2020-03-12 ✅ Patent 12,036,247 granted on 2024-07-16Multiple transgene recombinant adenovirus
#25 | 2020-01-30 ✅ Patent 11,999,973 granted on 2024-06-04Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter
#26 | 2020-01-23 ✅ Patent 11,660,286 granted on 2023-05-30Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
#27 | 2019-10-10 ✅ Patent 11,576,895 granted on 2023-02-14Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
#28 | 2019-07-09 ✅ Patent 10,342,778 granted on 2019-07-09Treatment of brain metastases using organonitro compound combination therapy
#29 | 2019-05-02 ✅ Patent 10,543,208 granted on 2020-01-28Treatment of gliomas using organonitro compound combination therapy
#30 | 2018-12-27 ✅ Patent 11,253,608 granted on 2022-02-22Recombinant adenoviruses carrying transgenes
#31 | 2016-07-14 ✅ Patent 10,149,832 granted on 2018-12-11Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
Also check out EpicentRx, Inc.'s (La Jolla, United States) applicant profile with 32 patent applications submitted.
306510 ⎘